Ospemifene

Last Updated: 02/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 263 publications

Hormone replacement therapy in gynecologic cancer: oncologic safety and alternative therapies.

Hormone replacement therapy in gynecologic cancer: oncologic safety and alternative therapies.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: September 15, 2025

Treatment of Menopausal Symptoms When Hormone Therapy Is Contraindicated.

Treatment of Menopausal Symptoms When Hormone Therapy Is Contraindicated.

Journal: Seminars in reproductive medicine

Published: September 02, 2025

Ospemifene May Provide Better Results Than Other Approaches to Treat Some Vaginal Symptoms of Menopause.

Ospemifene May Provide Better Results Than Other Approaches to Treat Some Vaginal Symptoms of Menopause.

Journal: American family physician

Published: June 18, 2025

Treatment patterns for genitourinary syndrome of menopause: a TriNetX analysis.

Treatment patterns for genitourinary syndrome of menopause: a TriNetX analysis.

Journal: The Canadian journal of urology

Published: May 07, 2025

State of the art in menopause: current best practice approaches from the IMS World Congress 2024, Melbourne.

State of the art in menopause: current best practice approaches from the IMS World Congress 2024, Melbourne.

Journal: Climacteric : the journal of the International Menopause Society

Published: February 10, 2025

Treating VVA improves symptom severity and patient-reported outcomes: 6-month PEONY results.

Treating VVA improves symptom severity and patient-reported outcomes: 6-month PEONY results.

Journal: Climacteric : the journal of the International Menopause Society

Published: February 07, 2025

Quality of life and Satisfaction With Ospemifene for Treating Vulvovaginal Atrophy in Breast Cancer Survivors: Six-Month Results From the PatiEnt SatisfactiON StudY (PEONY).

Quality of life and Satisfaction With Ospemifene for Treating Vulvovaginal Atrophy in Breast Cancer Survivors: Six-Month Results From the PatiEnt SatisfactiON StudY (PEONY).

Journal: Clinical breast cancer

Published: January 29, 2025

Ospemifene, a Selective Estrogen Receptor Modulator, Enhances Oligodendrocyte Myelination and Preserves Neurofunctions Against Injuries.

Ospemifene, a Selective Estrogen Receptor Modulator, Enhances Oligodendrocyte Myelination and Preserves Neurofunctions Against Injuries.

Journal: Journal of neurochemistry

Published: January 11, 2025

Review of current and emerging estrogen receptor agonists for vaginal atrophy.

Review of current and emerging estrogen receptor agonists for vaginal atrophy.

Journal: Expert opinion on pharmacotherapy

Published: January 08, 2025

Beyond hormones: 3PM approach to vaginal microbiota dynamics in postmenopausal women.

Beyond hormones: 3PM approach to vaginal microbiota dynamics in postmenopausal women.

Journal: The EPMA journal

Published: December 26, 2024

Comparison of estrogens and selective estrogen receptor modulators (SERMs) used for menopausal hormone therapy.

Comparison of estrogens and selective estrogen receptor modulators (SERMs) used for menopausal hormone therapy.

Journal: Menopause (New York, N.Y.)

Published: October 11, 2024

Midurethral sling in the treatment of mixed urinary incontinence: A literature review of functional outcomes and associated factors.

Midurethral sling in the treatment of mixed urinary incontinence: A literature review of functional outcomes and associated factors.

Journal: The French journal of urology

Published: September 22, 2024

Showing 1-12 of 263

Last Updated: 02/24/2026